Skip to main content
Log in

D-propoxyphene kinetics in man: Significance of a deep third compartment

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Data from a previously published single dose study of d-propoxyphene 65 mg given i.v. to 8 healthy subjects have been subjected to non linear regression analysis by a curve-fitting program to test the applicability of a 2- and a 3-compartment open model. Analysis of residuals (difference between observed and computed concentrations) revealed similar systematic deviations in all 8 subjects when the 2-compartment model was used (5–10 h negative residuals, after 13 h positive residuals). In contrast, curve-fit by a 3-compartment model (with two parallel peripheral compartments) was good with no systematic deviations. The data show that a terminal monoexponential decline in d-propoxyphene concentrations cannot be expected until 15–30 h after single dose administration, and that the determination of the corresponding half-life is rather inaccurate. Accordingly, precise steady state level predictions may be difficult to obtain from conventional single dose studies with d-propoxyphene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Dixon WJ, Brown MB, Engelman L, Frane JW, Hill MA, Jennrich RI, Toporek JD (1981) BMDP Statistical Software 1981. University of California Press, Berkeley

    Google Scholar 

  • Finkle BS, McClosky KL, Kiplinger GF, Bennett IF (1976) A national assessment of propoxyphene in postmortem medicolegal investigations 1972–1975. J Forensic Sci 21: 706–742

    Google Scholar 

  • Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York, pp 63–72 and 84–103

    Google Scholar 

  • Gibaldi M, Weintraub H (1971) Some considerations as to the determination and significance of biologic half-life. J Pharm Sci 60: 624–626

    Google Scholar 

  • Gram LF, Schou J, Way WL, Heltberg J, Bodin NO (1979) d-Propoxyphene kinetics after single oral and intravenous doses in man. Clin Pharmacol Ther 26: 473–482

    Google Scholar 

  • Inturrisi CE, Colburn WA, Vereby K, Dayton HE, Woody GE, O'Brien CP (1982) Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene. Clin Pharmacol Ther 31: 157–167

    Google Scholar 

  • Lund-Jacobsen H (1978) Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits. Acta Pharmacol Toxicol 42: 171–178

    Google Scholar 

  • Wagner JG, Welling PG, Sedman AJ (1972) Plasma concentrations of propoxyphene in man. Int J Clin Pharmacol Ther Toxicol 5: 381–388

    Google Scholar 

  • Wolen RL, Gruber CM, Kiplinger GF, Scholz NE (1971) Concentrations of propoxyphene in human plasma following oral, intramuscular, and intravenous administration. Toxicol Appl Pharmacol 19: 480–492

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gram, L.F., Schmidt, K., Christensen, F.N. et al. D-propoxyphene kinetics in man: Significance of a deep third compartment. Eur J Clin Pharmacol 26, 749–752 (1984). https://doi.org/10.1007/BF00541937

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541937

Key words

Navigation